サマリー

アレルギー性結膜炎は、花粉やカビの胞子などの物質に対するアレルギー反応によって引き起こされる眼の炎症です。
市場分析とインサイトアレルギー性結膜炎の世界市場
アレルギー性結膜炎の世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間、年率％で推移すると考えられます。
アレルギー性結膜炎には、季節性アレルギー性結膜炎、通年性アレルギー性結膜炎、巨大乳頭型結膜炎、春季ケラート結膜炎、アトピー性ケラート結膜炎などの種類があります。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のアレルギー性結膜炎市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、収益面での世界のアレルギー性結膜炎市場全体のサイズを含む、検証された信頼性の高い市場予測にアクセスすることができます。
本レポートは、世界のアレルギー性結膜炎市場において、競合他社よりも優位に立ち、永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のアレルギー性結膜炎市場を詳細に調査するために、独自の、そして業界で最も優れた調査・分析手法を用いています。
世界のアレルギー性結膜炎のスコープと市場規模
アレルギー性結膜炎市場は、プレイヤー別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のアレルギー性結膜炎市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てています。
タイプ別セグメント
季節性アレルギー性結膜炎
通年性アレルギー性結膜炎
巨大乳頭状結膜炎（Giant Papillary Conjunctivitis
Vernal Kerato Conjunctivitis（春季ケラート結膜炎
アトピー性ケラート結膜炎
用途別セグメント
抗ヒスタミン剤
充血除去剤
肥満細胞安定剤
オロパタジン
エピナスチン
非ステロイド系抗炎症薬
免疫療法
軟膏剤
その他
会社別
Aciex Therapeutics
アルコン
アラガン社
サンファーマ・アドバンスド・リサーチ
シリオン・セラピューティクス
ベーリンガーインゲルハイム（Boehringer Ingelheim
アトピクス・セラピューティクス
ライラ・ファーマシューティカルズ
Laboratoires Thea
Auven Therapeutics
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

ページTOPに戻る

目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allergic Conjunctivitis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Seasonal Allergic Conjunctivitis
1.2.3 Perennial Allergic Conjunctivitis
1.2.4 Giant Papillary Conjunctivitis
1.2.5 Vernal Kerato Conjunctivitis
1.2.6 Atopic Kerato Conjunctivitis
1.3 Market by Application
1.3.1 Global Allergic Conjunctivitis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Antihistamines
1.3.3 Decongestant
1.3.4 Mast Cell Stabilizers
1.3.5 Olopatadine
1.3.6 Epinastine
1.3.7 Nonsteroidal Anti-Inflammatory Drugs
1.3.8 Immunotherapy
1.3.9 Ointments
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Allergic Conjunctivitis Market Perspective (2017-2028)
2.2 Allergic Conjunctivitis Growth Trends by Region
2.2.1 Allergic Conjunctivitis Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Allergic Conjunctivitis Historic Market Size by Region (2017-2022)
2.2.3 Allergic Conjunctivitis Forecasted Market Size by Region (2023-2028)
2.3 Allergic Conjunctivitis Market Dynamics
2.3.1 Allergic Conjunctivitis Industry Trends
2.3.2 Allergic Conjunctivitis Market Drivers
2.3.3 Allergic Conjunctivitis Market Challenges
2.3.4 Allergic Conjunctivitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allergic Conjunctivitis Players by Revenue
3.1.1 Global Top Allergic Conjunctivitis Players by Revenue (2017-2022)
3.1.2 Global Allergic Conjunctivitis Revenue Market Share by Players (2017-2022)
3.2 Global Allergic Conjunctivitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Allergic Conjunctivitis Revenue
3.4 Global Allergic Conjunctivitis Market Concentration Ratio
3.4.1 Global Allergic Conjunctivitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allergic Conjunctivitis Revenue in 2021
3.5 Allergic Conjunctivitis Key Players Head office and Area Served
3.6 Key Players Allergic Conjunctivitis Product Solution and Service
3.7 Date of Enter into Allergic Conjunctivitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Allergic Conjunctivitis Breakdown Data by Type
4.1 Global Allergic Conjunctivitis Historic Market Size by Type (2017-2022)
4.2 Global Allergic Conjunctivitis Forecasted Market Size by Type (2023-2028)
5 Allergic Conjunctivitis Breakdown Data by Application
5.1 Global Allergic Conjunctivitis Historic Market Size by Application (2017-2022)
5.2 Global Allergic Conjunctivitis Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Allergic Conjunctivitis Market Size (2017-2028)
6.2 North America Allergic Conjunctivitis Market Size by Type
6.2.1 North America Allergic Conjunctivitis Market Size by Type (2017-2022)
6.2.2 North America Allergic Conjunctivitis Market Size by Type (2023-2028)
6.2.3 North America Allergic Conjunctivitis Market Share by Type (2017-2028)
6.3 North America Allergic Conjunctivitis Market Size by Application
6.3.1 North America Allergic Conjunctivitis Market Size by Application (2017-2022)
6.3.2 North America Allergic Conjunctivitis Market Size by Application (2023-2028)
6.3.3 North America Allergic Conjunctivitis Market Share by Application (2017-2028)
6.4 North America Allergic Conjunctivitis Market Size by Country
6.4.1 North America Allergic Conjunctivitis Market Size by Country (2017-2022)
6.4.2 North America Allergic Conjunctivitis Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Allergic Conjunctivitis Market Size (2017-2028)
7.2 Europe Allergic Conjunctivitis Market Size by Type
7.2.1 Europe Allergic Conjunctivitis Market Size by Type (2017-2022)
7.2.2 Europe Allergic Conjunctivitis Market Size by Type (2023-2028)
7.2.3 Europe Allergic Conjunctivitis Market Share by Type (2017-2028)
7.3 Europe Allergic Conjunctivitis Market Size by Application
7.3.1 Europe Allergic Conjunctivitis Market Size by Application (2017-2022)
7.3.2 Europe Allergic Conjunctivitis Market Size by Application (2023-2028)
7.3.3 Europe Allergic Conjunctivitis Market Share by Application (2017-2028)
7.4 Europe Allergic Conjunctivitis Market Size by Country
7.4.1 Europe Allergic Conjunctivitis Market Size by Country (2017-2022)
7.4.2 Europe Allergic Conjunctivitis Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allergic Conjunctivitis Market Size (2017-2028)
8.2 Asia-Pacific Allergic Conjunctivitis Market Size by Type
8.2.1 Asia-Pacific Allergic Conjunctivitis Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Allergic Conjunctivitis Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Allergic Conjunctivitis Market Share by Type (2017-2028)
8.3 Asia-Pacific Allergic Conjunctivitis Market Size by Application
8.3.1 Asia-Pacific Allergic Conjunctivitis Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Allergic Conjunctivitis Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Allergic Conjunctivitis Market Share by Application (2017-2028)
8.4 Asia-Pacific Allergic Conjunctivitis Market Size by Region
8.4.1 Asia-Pacific Allergic Conjunctivitis Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Allergic Conjunctivitis Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Allergic Conjunctivitis Market Size (2017-2028)
9.2 Latin America Allergic Conjunctivitis Market Size by Type
9.2.1 Latin America Allergic Conjunctivitis Market Size by Type (2017-2022)
9.2.2 Latin America Allergic Conjunctivitis Market Size by Type (2023-2028)
9.2.3 Latin America Allergic Conjunctivitis Market Share by Type (2017-2028)
9.3 Latin America Allergic Conjunctivitis Market Size by Application
9.3.1 Latin America Allergic Conjunctivitis Market Size by Application (2017-2022)
9.3.2 Latin America Allergic Conjunctivitis Market Size by Application (2023-2028)
9.3.3 Latin America Allergic Conjunctivitis Market Share by Application (2017-2028)
9.4 Latin America Allergic Conjunctivitis Market Size by Country
9.4.1 Latin America Allergic Conjunctivitis Market Size by Country (2017-2022)
9.4.2 Latin America Allergic Conjunctivitis Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allergic Conjunctivitis Market Size (2017-2028)
10.2 Middle East & Africa Allergic Conjunctivitis Market Size by Type
10.2.1 Middle East & Africa Allergic Conjunctivitis Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Allergic Conjunctivitis Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Allergic Conjunctivitis Market Share by Type (2017-2028)
10.3 Middle East & Africa Allergic Conjunctivitis Market Size by Application
10.3.1 Middle East & Africa Allergic Conjunctivitis Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Allergic Conjunctivitis Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Allergic Conjunctivitis Market Share by Application (2017-2028)
10.4 Middle East & Africa Allergic Conjunctivitis Market Size by Country
10.4.1 Middle East & Africa Allergic Conjunctivitis Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Allergic Conjunctivitis Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aciex Therapeutics
11.1.1 Aciex Therapeutics Company Details
11.1.2 Aciex Therapeutics Business Overview
11.1.3 Aciex Therapeutics Allergic Conjunctivitis Introduction
11.1.4 Aciex Therapeutics Revenue in Allergic Conjunctivitis Business (2017-2022)
11.1.5 Aciex Therapeutics Recent Developments
11.2 Alcon
11.2.1 Alcon Company Details
11.2.2 Alcon Business Overview
11.2.3 Alcon Allergic Conjunctivitis Introduction
11.2.4 Alcon Revenue in Allergic Conjunctivitis Business (2017-2022)
11.2.5 Alcon Recent Developments
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Allergic Conjunctivitis Introduction
11.3.4 Allergan Revenue in Allergic Conjunctivitis Business (2017-2022)
11.3.5 Allergan Recent Developments
11.4 Sun Pharma Advanced Research
11.4.1 Sun Pharma Advanced Research Company Details
11.4.2 Sun Pharma Advanced Research Business Overview
11.4.3 Sun Pharma Advanced Research Allergic Conjunctivitis Introduction
11.4.4 Sun Pharma Advanced Research Revenue in Allergic Conjunctivitis Business (2017-2022)
11.4.5 Sun Pharma Advanced Research Recent Developments
11.5 Sirion Therapeutics
11.5.1 Sirion Therapeutics Company Details
11.5.2 Sirion Therapeutics Business Overview
11.5.3 Sirion Therapeutics Allergic Conjunctivitis Introduction
11.5.4 Sirion Therapeutics Revenue in Allergic Conjunctivitis Business (2017-2022)
11.5.5 Sirion Therapeutics Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Allergic Conjunctivitis Introduction
11.6.4 Boehringer Ingelheim Revenue in Allergic Conjunctivitis Business (2017-2022)
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Atopix Therapeutics
11.7.1 Atopix Therapeutics Company Details
11.7.2 Atopix Therapeutics Business Overview
11.7.3 Atopix Therapeutics Allergic Conjunctivitis Introduction
11.7.4 Atopix Therapeutics Revenue in Allergic Conjunctivitis Business (2017-2022)
11.7.5 Atopix Therapeutics Recent Developments
11.8 Laila Pharmaceuticals
11.8.1 Laila Pharmaceuticals Company Details
11.8.2 Laila Pharmaceuticals Business Overview
11.8.3 Laila Pharmaceuticals Allergic Conjunctivitis Introduction
11.8.4 Laila Pharmaceuticals Revenue in Allergic Conjunctivitis Business (2017-2022)
11.8.5 Laila Pharmaceuticals Recent Developments
11.9 Laboratoires Thea
11.9.1 Laboratoires Thea Company Details
11.9.2 Laboratoires Thea Business Overview
11.9.3 Laboratoires Thea Allergic Conjunctivitis Introduction
11.9.4 Laboratoires Thea Revenue in Allergic Conjunctivitis Business (2017-2022)
11.9.5 Laboratoires Thea Recent Developments
11.10 Auven Therapeutics
11.10.1 Auven Therapeutics Company Details
11.10.2 Auven Therapeutics Business Overview
11.10.3 Auven Therapeutics Allergic Conjunctivitis Introduction
11.10.4 Auven Therapeutics Revenue in Allergic Conjunctivitis Business (2017-2022)
11.10.5 Auven Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer